Will integrin inhibitors have proangiogenic effects in the clinic?


Autoria(s): Weller M.; Reardon D.; Nabors B.; Stupp R.
Data(s)

2009

Identificador

http://serval.unil.ch/?id=serval:BIB_8511BDAE696E

isbn:1546-170X[electronic]

pmid:19584855

doi:10.1038/nm0709-726

isiid:000267806900017

Idioma(s)

en

Fonte

Nature Medicine, vol. 15, no. 7, pp. 726; author reply 727

Palavras-Chave #Animals; Glioblastoma/drug therapy; Humans; Integrins/antagonists & inhibitors; Neovascularization, Pathologic/chemically induced; Snake Venoms/adverse effects
Tipo

info:eu-repo/semantics/article

article